At its meeting on 19 September 2006 , the Reimbursement Committee had its first discussion of the reimbursement status of the following ATC groups:
- Medicinal products for cardiac therapy (C01)
- Peripheral vasodilators (C04)
- Vasoprotectives (C05)
In the fact box to your right, you can find a link to the documents from the Reimbursement Committee meetings (in Danish only).
For further information, please contact the Reimbursement Department, firstname.lastname@example.org.
The Danish Medicines Agency, 6 October 2006